Zobrazeno 1 - 10
of 33
pro vyhledávání: '"J P, Mulkay"'
Autor:
C. Van Steenkiste, Mike Cool, L Lasser, V. Lefèbvre, Thomas Vanwolleghem, Xavier Verhelst, K Venken, Suzanne Bourgeois, Stephanie Coulon, Isabelle Colle, J P Mulkay, J Decaestecker, G. Robaeys
Publikováno v:
Acta gastro-enterologica belgica
Objective : To describe comorbidities and concomitant medications in patients initiating treatment for hepatitis C virus (HCV) infection with direct-acting antiviral (DAA) regimens in Belgium. Methods : This was a noninterventional, observational, mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d331cb4617d3b2282c9059db226126d
https://doi.org/10.51821/84.1.851
https://doi.org/10.51821/84.1.851
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S, Bourgeois, J P, Mulkay, L, Lasser, G, Robaeys, B, Bastens, J, Delwaide, S, Pollet, M, Van den Enden
Publikováno v:
Acta gastro-enterologica Belgica. 82(1)
Direct-acting antivirals provide interferon-free treatments for chronic hepatitis C (CHC) virus infection. In Belgium, in 2016, access to these agents was limited to patients with advanced liver fibrosis stages F3 and F4. This study is the first to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3310c9dda7c9d12455313c604f5ab8ee
https://pubmed.ncbi.nlm.nih.gov/30888753
https://pubmed.ncbi.nlm.nih.gov/30888753
Publikováno v:
Acta gastro-enterologica Belgica. 79(2)
In 2010, there were an estimated 10 100 PWID in Belgium and 43% (34%-57%) were HCV infected. Understanding HCV transmission dynamics in high-risk populations and assessing the potential impact of improved HCV treatment strategies requires robust epid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb580a8a20a8e4ffdfe9516d23f9caef
https://pubmed.ncbi.nlm.nih.gov/27382943
https://pubmed.ncbi.nlm.nih.gov/27382943
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S, Bourgeois, P, Deltenre, J, Delwaide, J, Henrion, M, Adler, Ph, Langlet, J-P, Mulkay, F, Nevens, C, Brixko, C, Moreno
Publikováno v:
Acta gastro-enterologica Belgica. 77(4)
This was an observational, non-interventional, multicenter, phase IV study, in patients with genotype 1/4/5/6 chronic hepatitis C (CHC). The primary objectives were to evaluate SVR in patients with no or minimal fibrosis (METAVIR F0-F1) versus well e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71e4585a2f127cf8662a8ccafa4be062
https://pubmed.ncbi.nlm.nih.gov/25682628
https://pubmed.ncbi.nlm.nih.gov/25682628
Autor:
J P, Mulkay, S, Bourgeois, L, Lasser, C, De Galocsy, S, Tomasovic, Y, Horsmans, H, Van Vlierberghe, J, Stubbe
Publikováno v:
Acta gastro-enterologica Belgica. 77(1)
PROPHESYS was a prospective, international cohort study of monoinfected, treatment-naive chronic hepatitis C patients treated with a combination of peginterferon alfa-2a or alfa-2b and ribavirin.It included worldwide 7,163 patients from 19 countries
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc515efa87fe760606240a5cc7ae5685
https://pubmed.ncbi.nlm.nih.gov/24761689
https://pubmed.ncbi.nlm.nih.gov/24761689
Autor:
J P, Mulkay
Publikováno v:
Revue medicale de Bruxelles. 33(4)
Hepatitis B virus infection is more prevalent than human immunodeficiency virus (HIV) infection and hepatitis C virus infection. Chronic hepatitis B (CHB) is a serious disease that can lead to severe complications as cirrhosis and hepatocellular carc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bdd215939eb3b227c8c1292256088d3f
https://pubmed.ncbi.nlm.nih.gov/23091924
https://pubmed.ncbi.nlm.nih.gov/23091924
Autor:
F D'Heygere, Réginald Brenard, H. Van Vlierberghe, J. Delwaide, P. Langlet, A. Laureys, Frederik Nevens, M. Adler, L Lasser, Yves Horsmans, P.P. Michielsen, J P Mulkay, Jean Henrion
Publikováno v:
Alimentary pharmacology and therapeutics
Alimentary Pharmacology and Therapeutics, Vol. 30, no. 4, p. 352-363 (2009)
Alimentary Pharmacology and Therapeutics, Vol. 30, no. 4, p. 352-363 (2009)
P>Background The combination therapy of pegylated-interferon-alpha 2a plus ribavirin is considered as the standard of care for patients with chronic hepatitis C. A sustained viral response is obtained in 40-50% of naive patients with genotype 1 and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::808b849dbf5a9710032621b47872f366
https://pubmed.ncbi.nlm.nih.gov/19485978
https://pubmed.ncbi.nlm.nih.gov/19485978
Autor:
G, Robaeys, F, Buntinx, E, Bottieau, S, Bourgeois, R, Brenard, I, Colle, J, De Bie, C, Matheï, J P, Mulkay, P, Van Damme, M, Van Ranst, R, Verrando, P, Michielsen, N, Bourgeois, Ch, de Galocsy, J, Delwaide, J, Henrion, Y, Horsmans, H, Reynaert, D, Sprengers
Publikováno v:
Acta gastro-enterologica Belgica. 68(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ba9ae6766aa74797d1014dce1e25fe7
https://pubmed.ncbi.nlm.nih.gov/15832586
https://pubmed.ncbi.nlm.nih.gov/15832586